Q1 2021 Roche Holding AG Corporate Sales Call Transcript
Kindly note that the webinar is being recorded. (Operator Instructions)
At this time, it's my pleasure to introduce you to Karl Mahler, Head of Investor Relations and Group Planning. Karl, the stage is yours.
Yes. Thanks a lot, Henrik. Welcome to our Q1 Conference Call. Hope you are all safe and well on your side. We have about 1.5 hours reserved for you. 50%, half of that, is presentation. Half of that is Q&A. So you should have plenty of time, sufficient time, for the questions and answers. (Operator Instructions)
Personally, I believe that we had a really good start into the year, with very strong new product sales for Pharma, excellent Diagnostic business. So I would say, Roche is offering some stability, good stability, in these very unstable times.
And with this one, over to you, Severin.
Thank you, Karl. And actually, you summarized it well. We had a good start into 2021.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |